$2.38
(Market cap
$1,774 Mln
Revenue (TTM)
$570 Mln
P/E Ratio
166.9
P/B Ratio
3.4
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
$0 Mln
-
ROE
0 %
-
ROCE
-- %
-
Industry P/E
51.35
-
EV/EBITDA
109
-
Debt to Equity
0
-
Book Value
$--
-
EPS
$0.2
-
Face value
--
-
Shares outstanding
50,640,970
10 Years Aggregate
CFO
$-124.85 Mln
EBITDA
$-333.57 Mln
Net Profit
$-234.84 Mln
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
AtriCure (ATRC)
| 0.5 | 31.7 | 36.9 | 26.2 | -10.1 | -13.1 | 10.3 |
|
BSE Sensex*
| -8.4 | 0.6 | 0.9 | -4.1 | 5.5 | 8.1 | 10.6 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
AtriCure (ATRC)
| 29.5 | -14.3 | -19.6 | -36.2 | 24.9 | 71.2 | 6.2 |
|
S&P Small-Cap 600
| 4.0 | 7.0 | 13.9 | -17.4 | 25.3 | 9.6 | 20.9 |
|
BSE Sensex
| 9.1 | 8.1 | 18.7 | 4.4 | 22.0 | 15.8 | 14.4 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
AtriCure (ATRC)
|
39.8 | 1,774.5 | 569.6 | 10.6 | 3.0 | 2.1 | 166.9 | 3.4 |
| 107.3 | 179,511.3 | 46,585.0 | 5,425.0 | 13.3 | 20.8 | 32.6 | 3.4 | |
| 0.1 | 2.3 | 16.4 | -2.1 | 7.6 | -- | -- | 29.9 | |
| 199.1 | 135,324.8 | 25,107.0 | 4,004.0 | 15.4 | 7.6 | 31.9 | 2.4 | |
| 83.7 | 47,578.4 | 6,512.3 | 1,004.9 | 13.8 | 19.5 | 49.2 | 4.7 | |
| 361.8 | 120,918.8 | 11,034.4 | 3,138.8 | 33.8 | 17.3 | 38 | 6.5 | |
| 576.4 | 212,686.4 | 46,336.0 | 6,978.0 | 18.6 | 13.1 | 28.9 | 3.8 | |
| 71.0 | 213.8 | 36.1 | 10.5 | 33.9 | 8.7 | 20.5 | 1.7 | |
| 337.0 | 25,025.8 | 3,326.5 | 564.9 | 15.3 | 18.3 | 47.8 | 8.5 |
Shareholding Pattern
View DetailsAbout AtriCure (ATRC)
AtriCure, Inc. engages in the development, manufacture, and sale of devices for surgical ablation of cardiac tissue, exclusion of the left atrial appendage, and temporarily blocking pain by ablating peripheral nerves to medical centers in the United... States, the Asia-Pacific, and internationally. It offers Isolator Synergy Ablation System clamps, a single-use disposable radio frequency products; multifunctional pens and linear ablation devices, a single-use disposable RF products for the treatment of cardiac arrhythmias; cryoICE Cryoablation System that enables the user to make linear ablations of varied lengths; and EPi-Sense Systems, a single-use disposable device used for the treatment of symptomatic, drug-refractory, and long-standing persistent atrial fibrillation. It also provides cryoSPHERE probe, which provides temporary pain relief by applying cryothermic energy to targeted intercoastal peripheral nerves in the ribcage; AtriClip System, an implantable device coupled to a single-use disposable applier; cryoXT probes, a cryoablation device designed specifically for Cryo Nerve Block therapy; LARIAT System, a solution for soft-tissue closure; Lumitip dissectors to separate tissues to provide access to key anatomical structures that are targeted for ablation; Glidepath guides for placement of clamps; and Subtle Cannula's to support access for EPi-Sense catheters. In addition, the company sells various reusable cardiac surgery instruments. It markets and sells its products through independent distributors and direct sales personnel. The company was incorporated in 2000 and is headquartered in Mason, Ohio. Read more
-
CEO, President & Director
Mr. Michael H. Carrel
-
CEO, President & Director
Mr. Michael H. Carrel
-
Headquarters
Mason, OH
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
FAQs for AtriCure (ATRC)
What is the current share price of AtriCure Inc (ATRC) Today?
The share price of AtriCure Inc (ATRC) is $39.75 (NASDAQ) as of 28-Jul-2026 16:00 EDT. AtriCure Inc (ATRC) has given a return of -10.12% in the last 3 years.
What is the current PB & PE ratio of AtriCure Inc (ATRC)?
The P/E ratio of AtriCure Inc (ATRC) is 166.86 times as on 24-Jul-2026, a 225 premium to its peers’ median range of 51.35 times.
The P/B ratio of AtriCure Inc (ATRC) is 3.44 times as on 24-Jul-2026, a 1 premium to its peers’ median range of 3.42 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
-168.89
|
3.93
|
|
2024
|
-32.21
|
3.12
|
|
2023
|
-54.46
|
3.56
|
|
2022
|
-43.85
|
4.46
|
|
2021
|
62.79
|
6.52
|
What is the 52 Week High and Low of AtriCure Inc (ATRC)?
The 52-week high and low of AtriCure Inc (ATRC) are Rs 43.18 and Rs 25.37 as of 29-Jul-2026.
What is the market cap of AtriCure Inc (ATRC)?
AtriCure Inc (ATRC) has a market capitalisation of $ 1,774 Mln as on 24-Jul-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in AtriCure Inc (ATRC)?
Before investing in AtriCure Inc (ATRC), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.